[HTML][HTML] Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma …
JA Alamoudi, TA El-Masry, M Nasr, IT Ibrahim… - Pharmaceuticals, 2024 - mdpi.com
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced …
JA Alamoudi, TA El-Masry, M Nasr… - Pharmaceuticals …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced …
JA Alamoudi, TA El-Masry, M Nasr, IT Ibrahim… - …, 2024 - go.gale.com
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced …
JA Alamoudi, TA El-Masry, M Nasr… - Pharmaceuticals …, 2024 - europepmc.org
Background Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
[PDF][PDF] Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma …
JA Alamoudi, TA El-Masry, M Nasr, IT Ibrahim… - …, 2024 - researchgate.net
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
[HTML][HTML] Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma …
JA Alamoudi, TA El-Masry, M Nasr, IT Ibrahim… - …, 2024 - ncbi.nlm.nih.gov
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced …
JA Alamoudi, TA El-Masry, M Nasr, IT Ibrahim… - …, 2024 - search.proquest.com
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced …
JA Alamoudi, TA El-Masry, M Nasr… - Pharmaceuticals …, 2024 - search.ebscohost.com
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
[PDF][PDF] Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma …
JA Alamoudi, TA El-Masry, M Nasr, IT Ibrahim… - …, 2024 - researchgate.net
Background: Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced …
JA Alamoudi, TA El-Masry, M Nasr… - Pharmaceuticals …, 2024 - europepmc.org
Background Orlistat (ORL) is an effective irreversible inhibitor of the lipase enzyme, and it
possesses anticancer effects and limited aqueous solubility. This study was designed to …
possesses anticancer effects and limited aqueous solubility. This study was designed to …